Systemic Infusion of Expanded CD133+ Cells and Expanded CD133+ Cell-Derived EVs for the Treatment of Ischemic Cardiomyopathy in a Rat Model of AMI

• Main Authors: Addeli B. B. Angulski (Author), Luiz Guilherme A. Capriglione (Author), Fabiane Barchiki (Author), Paulo Brofman (Author), Marco A. Stimamiglio (Author), Alexandra C. Senegaglia (Author), Alejandro Correa (Author)
• Format: Book
• Published: Hindawi Limited, 2019-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Myocardial infarction is a leading cause of death among all cardiovascular diseases. Cell therapies using a cell population enriched with endothelial progenitor cells (EPCs), expanded CD133+ cells, have promise as a therapeutic option for the treatment of ischemic areas after infarction. Recently, s...